Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Axovant Gene TherapiesSavaraGlycoMimeticsHarrow HealthCannTrust
SymbolNASDAQ:AXGTNASDAQ:SVRANASDAQ:GLYCNASDAQ:HROWNYSE:CTST
Price Information
Current Price$3.41$2.52$2.95$5.33C$0.64
52 Week RangeBuyBuyBuyBuyHold
Beat the Market™ Rank
Overall Score1.91.52.12.01.2
Analysis Score3.43.33.33.53.1
Community Score2.62.42.72.12.4
Dividend Score0.00.00.00.00.0
Ownership Score3.01.04.04.00.0
Earnings & Valuation Score0.60.60.60.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$16.70$8.32$8.75$12.50C$4.50
% Upside from Price Target389.74% upside230.16% upside196.61% upside134.52% upside605.33% upside
Trade Information
Market Cap$122.99 million$126.29 million$130.31 million$141.42 millionN/A
Beta1.590.942.540.812.08
Average Volume157,900285,645298,943119,773N/A
Sales & Book Value
Annual RevenueN/AN/AN/A$51.17 millionC$35.22 million
Price / SalesN/AN/AN/A2.672.56
CashflowN/A$5.36 per shareN/AN/AN/A
Price / CashN/A0.47N/AN/AN/A
Book Value$2.47 per share$1.67 per share$3.41 per share$0.59 per shareC$1.27 per share
Price / BookN/AN/AN/A9.030.50
Profitability
Net Income$-129,070,000.00$-78,170,000.00$-57,890,000.00$170,000.00C$-10,460,000.00
EPS($8.02)$4.57($1.34)($0.29)N/A
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/A59.22∞
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-47.54%N/A
Return on Equity (ROE)-241.62%-53.48%-31.76%-32.90%N/A
Return on Assets (ROA)-75.95%-40.16%-29.29%-14.74%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.28%0.28%0.02%1.19%N/A
Current Ratio1.09%13.90%14.78%1.95%N/A
Quick Ratio1.09%13.90%14.78%1.65%N/A
Ownership Information
Institutional Ownership Percentage31.58%46.02%91.00%38.90%0.20%
Insider Ownership Percentage5.50%4.77%26.80%12.43%N/A
Miscellaneous
Employees45N/A50N/A576
Shares Outstanding36.82 million52.19 million43.58 million25.62 million141.49 million
Next Earnings Date6/9/2020 (Estimated)8/13/2020 (Estimated)8/6/2020 (Estimated)8/12/2020 (Estimated)6/2/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.